$CE

Celsius Shares Reclaim 20-Day and 50-Day Moving Averages as Momentum Shifts - Celsius Holdings (NASDAQ:CE

Celsius Holdings (NASDAQ:CE) shares rebounded as price reclaimed the 20- and 50-day moving averages. The stock is about 9.3% above its 20-day SMA ($29.13) and 3.8% above its 50-day SMA ($30.65), but still ~12% below the 100-day SMA ($36.18) and ~27.3% below the 200-day SMA ($43.77). UBS maintained a Buy rating but cut its target to $50 from $55. Shares were up 4.36% to $33.26.

Original reporting
Published Jul 2, 2026, 3:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 2, 2026, 4:18 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Celsius Shares Reclaim 20-Day and 50-Day Moving Averages as Momentum Shifts - Celsius Holdings (NASDAQ:CE — source image
Decision brief

The 30-second read

$CENeutralLow
01

Why it matters

The actionable element is the analyst price-target reduction (UBS: $50 vs $55) combined with improving short-term momentum indicators; this mix often leads to choppy trading rather than a clean trend reversal.

02

Market read

Traders may use the cited resistance ($33.50) and support ($27.50) plus the PT cut to manage tactical long/short setups around a momentum rebound.

03

What to watch

The article doesn’t discuss any new company-specific operating catalyst (sales, guidance, product, distribution changes); technicals may dominate until a fundamental update arrives.

Relevance 4/10Novelty 4/10Timing: today’s rebound framing with cited $33.26 print and nearby $33.50 resistance

Background

Celsius Holdings is an energy drink company; the piece frames the move as a technical catch-up bounce after a prolonged slide.

Company-level read

Ticker impact

$CENeutralMedium confidence
Context

Article says CELH reclaimed the 20- and 50-day moving averages and cites UBS lowering its price target to $50 from $55.

Expected impact

Likely supports continued short-term bounce attempts toward resistance near $33.50, but upside may stall until the stock reclaims the 100-day area.

Evidence & confidence

The only fresh fundamental datapoint is the analyst price-target cut; the rest is technical framing and current levels, which typically drive tactical trading rather than a durable rerating.

Market effects

Limited sector read-through; focuses on one beverage name’s technical rebound and analyst stance.

None stated beyond North America revenue concentration.

None stated.

Counterpoint

Reclaiming short moving averages can be a bear-market rally; failure near $33.50 could quickly reverse momentum given the stock remains well below 100/200-day levels.

Key entities

  • Celsius Holdings

    Subject of the article; stock is described as reclaiming 20- and 50-day moving averages while remaining below longer-term MAs.

  • UBS analyst Peter Grom

    Maintained Buy rating but lowered price target to $50 from $55.

Related articles

$CELow

Celanese Corp (CE): Results of Operations and Financial Condition

Celanese Corp (CE) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.2 3 q220268-kex992.htm EX-99.2 Document Exhibit 99.2 Non-U.S. GAAP Financial Measures and Supplemental Information August 4, 2026 In this document, the terms the "Company," "we" and "our" refer to Celanese Corporation and its subsidiaries on a consolidated basis. Purpose Th

$CEMed

Celanese Corporation: Amsterdam District Court Rules in Favor of Celanese and its Co-Defendants in Shell and Repsol Cases, Dismissing All Claims

Celanese (NYSE: CE) said the Amsterdam District Court dismissed Shell Chemicals Europe’s damages claim and a Repsol entities claim seeking declaratory judgment of liability against Celanese and co-defendants. The cases stem from follow-on litigation related to a 2020 European Commission settlement over past ethylene purchases in North-Western Europe.

$GDDYMed

Wall Street Is Losing Confidence in GoDaddy’s (GDDY) AI Strategy. Should Investors?

GoDaddy (NYSE:GDDY) reported Q results of $1.83 EPS and about $1.30B revenue, both above consensus, but the stock fell about 12%. Bookings rose 6% to $1.4B, while Applications and Commerce bookings growth slowed to 7% from 9%. Analysts cited concerns over agentic AI transition noise; management is accelerating Airo and cutting legacy investment. Q3 revenue guidance is $1.32B-$1.34B.

$BAMed

Boeing's 777X Headache Just Got Worse: Lufthansa Says No Thanks

Lufthansa said it will not accept the earliest built examples of Boeing’s 777-9, joining Emirates, as some aircraft have been in storage since 2019-2020. Boeing’s 777X program remains uncertified and is now about 6-7 years behind schedule, with certification targeted for late 2026 or early 2027 and first Lufthansa deliveries in Q1 2027. Boeing took a $4.9B pre-tax charge in 2025.

$DVAMed

DaVita Shares Rise After TD Cowen Upgrades Stock to Buy

DaVita HealthCare Partners (NYSE:DVA) rose about 2.1% premarket after TD Cowen upgraded it from Hold to Buy and raised its price target to $220 from $201, citing improving competitive position and long-term growth. The upgrade followed DaVita’s Q2 2026 results: adjusted EPS $4.02 vs $3.92 expected, revenue about $3.55B vs estimates, while guidance stayed unchanged.